Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH announces changes to its Code of Practice
The latest (27th) edition of the Code of Practice is now available.
Changes include guidance note on advertising POM medicines

The National Office of Animal Health (NOAH) has announced changes to its Code of Practice for the Promotion of Animal Medicines.

The changes include a revised Guidance Note on advertising POM medicines, giving guidance on how to ensure the important communication channel that promotion brings is used responsibly.

There is also a new Guidance Note to help companies involved in international conferences, and the process for reviewing and making changes to the code has also been formalised.

Commenting Dawn Howard, Noah chief executive said: ‘“NOAH believes in the benefit of advertising POMs to prescribers and professional keepers of animals, as specified in the Veterinary Medicines regulations, but we believe that this needs great care and responsibility in the preparation of advertisements and promotions, to support the responsible use of these products.”

She added that every NOAH member, in addition to non-member participants in the NOAH Compendium, signs up to the NOAH code ‘which goes above and beyond any regulatory requirements’.

“This can give give prescribers and users of animal medicines confidence in the promotions they may receive from NOAH members,” she said.

The latest (27th) edition of the Code of Practice is now available. Regularly updated to ensure it stays relevant, the 27th edition is effective from 1 December.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.